Targeting estrogen-regulated system xc − promotes ferroptosis and endocrine sensitivity of ER+ breast cancer

Abstract Estrogen receptor positive (ER+) breast cancer accounts for approximately 70% of cases. Endocrine therapies targeting estrogen are the first line therapies for ER+ breast cancer. However, resistance to these therapies occurs in about half of patients, leading to decreased survival rates. In...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Jiawei Cao, Tong Zhou, Tao Wu, Rixu Lin, Ju Huang, Dejin Shi, Jiawei Yu, Yinrui Ren, Changrui Qian, Licai He, Guang Wu, Zhixiong Dong, Shaofei Yuan, Haihua Gu
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Nature Publishing Group 2025-01-01
סדרה:	Cell Death and Disease
גישה מקוונת:	https://doi.org/10.1038/s41419-025-07354-0
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!